Radiopharm Theranostics (ASX: RAD, NASDAQ: RADX) received approval from its Data Safety and Monitoring Committee to advance its 177Lu-RAD202 treatment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA